Related Experiment Video
Updated: Jan 10, 2026

15:49
Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
32.5K
A Novel Scoring System for Pilonidal Disease: Predicting Complications and Guiding Surgical Management
Ahmed H Amer1, Emma Camilleri2, Fouad Ashoush3
1General Surgery, Tanta University, Tanta, EGY.
Cureus
|November 27, 2025
Summary
A new Hazem-Talaat score helps predict pilonidal disease recurrence, aiding surgical planning. Higher scores indicate increased risk, guiding treatment for better patient outcomes.
Area of Science:
- Surgical innovation in managing chronic sacrococcygeal conditions.
- Development of predictive tools for patient stratification.
Background:
- Pilonidal disease is a chronic sacrococcygeal condition with high recurrence and complication rates.
- Lack of a standardized classification system hinders consistent treatment and prognosis prediction.
Purpose of the Study:
- To develop and validate the Hazem-Talaat score, a novel preoperative system for assessing pilonidal disease severity.
- To predict recurrence and guide surgical planning for pilonidal disease.
Main Methods:
- Prospective study of 156 patients (18-45 years) with primary or recurrent pilonidal disease.
- Incorporation of preoperative variables (BMI, sex, pits, diabetes, etc.) into the Hazem-Talaat score.
- Standardized surgical excision and off-midline closure, with a minimum six-month follow-up.
Main Results:
- Recurrence observed in 12.2% of patients; wound dehiscence in 16.7%.
- Recurrence significantly associated with male gender, higher BMI, diabetes, prior recurrence, and specific pit characteristics.
- Higher Hazem-Talaat scores correlated with increased recurrence risk (p < 0.001), with a cut-off of 21 identified.
Conclusions:
- The Hazem-Talaat score is an objective tool for predicting pilonidal disease recurrence and stratifying patients.
- Application of the score can improve surgical planning and patient outcomes.
- Further multicenter validation is recommended to confirm the score's utility.

